87 related articles for article (PubMed ID: 29408457)
41. MEF2D overexpression contributes to the progression of osteosarcoma.
Yu H; Sun H; Bai Y; Han J; Liu G; Liu Y; Zhang N
Gene; 2015 Jun; 563(2):130-5. PubMed ID: 25814384
[TBL] [Abstract][Full Text] [Related]
42. MEF2D Functions as a Tumor Suppressor in Breast Cancer.
Wang X; Shen H; Chen Y; Zhang Y; Wang J; Liu S; Xu B; Wang H; Frangou C; Zhang J
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791246
[TBL] [Abstract][Full Text] [Related]
43. Silencing of ETV6/RUNX1 abrogates PI3K/AKT/mTOR signaling and impairs reconstitution of leukemia in xenografts.
Fuka G; Kantner HP; Grausenburger R; Inthal A; Bauer E; Krapf G; Kaindl U; Kauer M; Dworzak MN; Stoiber D; Haas OA; Panzer-Grümayer R
Leukemia; 2012 May; 26(5):927-33. PubMed ID: 22094587
[TBL] [Abstract][Full Text] [Related]
44. Knockdown of MEF2D inhibits the development and progression of B-cell acute lymphoblastic leukemia.
Chang N; Feng J; Liao P; Hu Y; Li M; He Y; Li Y
Transl Cancer Res; 2023 Feb; 12(2):287-300. PubMed ID: 36915581
[TBL] [Abstract][Full Text] [Related]
45. Common origin of the human synovial sarcoma associated SS18 and SS18L1 gene loci.
de Bruijn DR; Geurts van Kessel A
Cytogenet Genome Res; 2006; 112(3-4):222-6. PubMed ID: 16484776
[TBL] [Abstract][Full Text] [Related]
46. Constitutive Kit activity triggers B-cell acute lymphoblastic leukemia-like disease in mice.
Weidemann RR; Behrendt R; Schoedel KB; Müller W; Roers A; Gerbaulet A
Exp Hematol; 2017 Jan; 45():45-55.e6. PubMed ID: 27664314
[TBL] [Abstract][Full Text] [Related]
47. MEF2D/Wnt/β-catenin pathway regulates the proliferation of gastric cancer cells and is regulated by microRNA-19.
Xu K; Zhao YC
Tumour Biol; 2016 Jul; 37(7):9059-69. PubMed ID: 26762410
[TBL] [Abstract][Full Text] [Related]
48. FOXP1 and PAX5 are rare but recurrent translocations partners in acute lymphoblastic leukemia.
Put N; Deeren D; Michaux L; Vandenberghe P
Cancer Genet; 2011 Aug; 204(8):462-4. PubMed ID: 21962897
[TBL] [Abstract][Full Text] [Related]
49. Aberrant expression of homeobox gene SIX1 in Hodgkin lymphoma.
Nagel S; Meyer C; Kaufmann M; Drexler HG; MacLeod RA
Oncotarget; 2015 Nov; 6(37):40112-26. PubMed ID: 26473286
[TBL] [Abstract][Full Text] [Related]
50. miR-103 promotes 3T3-L1 cell adipogenesis through AKT/mTOR signal pathway with its target being MEF2D.
Li M; Liu Z; Zhang Z; Liu G; Sun S; Sun C
Biol Chem; 2015 Mar; 396(3):235-44. PubMed ID: 25400071
[TBL] [Abstract][Full Text] [Related]
51. MEF2D and MEF2C pathways disruption in sporadic and familial ALS patients.
Arosio A; Sala G; Rodriguez-Menendez V; Grana D; Gerardi F; Lunetta C; Ferrarese C; Tremolizzo L
Mol Cell Neurosci; 2016 Jul; 74():10-7. PubMed ID: 26921792
[TBL] [Abstract][Full Text] [Related]
52. Detection and quantification of TEL/AML1 fusion transcripts by polymerase chain reaction in childhood acute lymphoblastic leukemia.
Nakao M; Yokota S; Horiike S; Taniwaki M; Kashima K; Sonoda Y; Koizumi S; Takaue Y; Matsushita T; Fujimoto T; Misawa S
Leukemia; 1996 Sep; 10(9):1463-70. PubMed ID: 8751464
[TBL] [Abstract][Full Text] [Related]
53. Diagnostic utility of dual-color break-apart chromogenic in situ hybridization for the detection of rearranged SS18 in formalin-fixed, paraffin-embedded synovial sarcoma.
Motoi T; Kumagai A; Tsuji K; Imamura T; Fukusato T
Hum Pathol; 2010 Oct; 41(10):1397-404. PubMed ID: 20594581
[TBL] [Abstract][Full Text] [Related]
54. A typical bedside-to-bench investigation of leukemogenic driver MEF2D fusion reveals new targeted therapy in B-cell acute lymphoblastic leukemia.
Zhang H; Meng G
Blood Sci; 2022 Jul; 4(3):161-163. PubMed ID: 36518591
[TBL] [Abstract][Full Text] [Related]
55. SS18 regulates pluripotent-somatic transition through phase separation.
Kuang J; Zhai Z; Li P; Shi R; Guo W; Yao Y; Guo J; Zhao G; He J; Xu S; Wu C; Yu S; Zhou C; Wu L; Qin Y; Cai B; Li W; Wu Z; Li X; Chu S; Yang T; Wang B; Cao S; Li D; Zhang X; Chen J; Liu J; Pei D
Nat Commun; 2021 Jul; 12(1):4090. PubMed ID: 34215745
[TBL] [Abstract][Full Text] [Related]
56. Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working Group.
Ohki K; Butler ER; Kiyokawa N; Hirabayashi S; Bergmann AK; Möricke A; Boer JM; Cavé H; Cazzaniga G; Yeoh AEJ; Sanada M; Imamura T; Inaba H; Mullighan CG; Loh ML; Norén-Nyström U; Shih LY; Zaliova M; Pui CH; Haas OA; Harrison CJ; Moorman AV; Manabe A
Leukemia; 2023 Jan; 37(1):212-216. PubMed ID: 36309560
[No Abstract] [Full Text] [Related]
57. Erk Negative Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia.
Shojaee S; Caeser R; Buchner M; Park E; Swaminathan S; Hurtz C; Geng H; Chan LN; Klemm L; Hofmann WK; Qiu YH; Zhang N; Coombes KR; Paietta E; Molkentin J; Koeffler HP; Willman CL; Hunger SP; Melnick A; Kornblau SM; Müschen M
Cancer Cell; 2015 Jul; 28(1):114-28. PubMed ID: 26073130
[TBL] [Abstract][Full Text] [Related]
58. [Adult acute lymphoblastic leukemia: update on pathophysiology and management].
Hayakawa F
Rinsho Ketsueki; 2018; 59(5):497-503. PubMed ID: 29877239
[TBL] [Abstract][Full Text] [Related]
59. B-1 progenitor acute lymphoid leukemia.
Yoshimoto M
Blood; 2019 Jun; 133(24):2557-2558. PubMed ID: 31196877
[TBL] [Abstract][Full Text] [Related]
60. A novel transcript of MEF2D promotes myoblast differentiation and its variations associated with growth traits in chicken.
Ouyang H; Yu J; Chen X; Wang Z; Nie Q
PeerJ; 2020; 8():e8351. PubMed ID: 32117604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
